SupplySide West Sneak Peek: Omega-3 Excellence
Epax offers a wide range of high-quality omega-3 concentrates for the nutraceutical business-to-business segment.
Epax offers a wide range of high-quality omega-3 concentrates for the nutraceutical business-to-business segment, as well as pharmaceutical intermediates and active pharmaceutical ingredients. Recently, the company received the Frost & Sullivan Product Differentiation Excellence Award that recognizes Epax’s condition-specific range of concentrated EPA/DHA omega-3 ingredient products and the company’s success in carving out a niche in a crowded market. Epax is a world leader in marine-derived omega-3 fatty acid concentrates. The company says it has one of the best purity profiles in the industry. The Epax group is headquartered in Oslo, Norway, with cGMP manufacturing facilities in Ålesund, Norway, and Seal Sands, UK, and is a 50/50 joint venture between Aker BioMarine ASA and Lindsay Goldberg LLC.
Booth #25039
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
